Search: id:"swepub:oai:lup.lub.lu.se:87384b4c-3ded-4b9e-b730-ab0d393d77be" >
Prognostic value of...
Prognostic value of quality of life scores for time to progression (TTP) and overall survival time (OS) in advanced breast cancer
- Article/chapterEnglish2003
Publisher, publication year, extent ...
Numbers
-
LIBRIS-ID:oai:lup.lub.lu.se:87384b4c-3ded-4b9e-b730-ab0d393d77be
-
https://lup.lub.lu.se/record/306077URI
-
https://doi.org/10.1016/S0959-8049(02)00775-XDOI
-
https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-65766URI
-
http://kipublications.ki.se/Default.aspx?queryparsed=id:1957501URI
Supplementary language notes
-
Language:English
-
Summary in:English
Part of subdatabase
Classification
-
Subject category:art swepub-publicationtype
-
Subject category:ref swepub-contenttype
Notes
-
The purpose of the study was to investigate whether baseline quality of life (QoL) and changes in QoL scores from baseline are prognostic for time to progression (TTP) and/or overall survival (OS) in patients with advanced breast cancer receiving docetaxel (T) or sequential methotrexate and 5-fluorouracil (MF). QoL was assessed at baseline and before each treatment using the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire (QLQ-C30). Survival curves and probabilities were estimated using the Kaplan-Meier technique. The Cox proportional hazards regression model was used for both the univariate and multivariate analyses to explore relationships between baseline QoL variables and TTP, as well as OS. In the univariate analysis, more severe pain and fatigue at baseline were predictive for a shorter OS; global QoL, physical functioning and appetite loss had a borderline significance (P=0.0130 for global QoL; P=0.0256 for physical functioning: P=0.0149 for appetite loss). World Health Organization (WHO) performance status was significantly predictive for OS. In the multivariate analysis, more severe pain at baseline was predictive for a shorter OS. In contrast, baseline QoL had no prognostic value for the duration of TTP. QoL change scores from baseline QoL predicted neither OS nor TTP. Our findings suggest that while QoL measurements are important in evaluating patients' QoL, they have no great importance in predicting primary clinical endpoints such as TTP or OS in advanced breast cancer patients. (C) 2002 Elsevier Science Ltd. All rights reserved.
Subject headings and genre
Added entries (persons, corporate bodies, meetings, titles ...)
-
Hakamies-Blomqvist, L
(author)
-
Sjostrom, J
(author)
-
Pluzanska, A
(author)
-
Ottoson, S
(author)
-
Mouridsen, H
(author)
-
Bengtsson, NO
(author)
-
Bergh, JKarolinska Institutet
(author)
-
Malmström, PerLund University,Lunds universitet,Bröstcancer-genetik,Sektion I,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Breastcancer-genetics,Section I,Department of Clinical Sciences, Lund,Faculty of Medicine(Swepub:lu)onk-pma
(author)
-
Valvere, V
(author)
-
Tennvall, L
(author)
-
Blomqvist, CUppsala universitet,Institutionen för onkologi, radiologi och klinisk immunologi,Onko
(author)
-
Karolinska InstitutetBröstcancer-genetik
(creator_code:org_t)
Related titles
-
In:European Journal of Cancer39:10, s. 1370-13761879-08520959-8049
Internet link
Find in a library
To the university's database
- By the author/editor
-
Luoma, ML
-
Hakamies-Blomqvi ...
-
Sjostrom, J
-
Pluzanska, A
-
Ottoson, S
-
Mouridsen, H
-
show more...
-
Bengtsson, NO
-
Bergh, J
-
Malmström, Per
-
Valvere, V
-
Tennvall, L
-
Blomqvist, C
-
show less...
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
-
MEDICAL AND HEAL ...
-
and Clinical Medicin ...
-
and Cancer and Oncol ...
- Articles in the publication
-
European Journal ...
- By the university
-
Lund University
-
Uppsala University
-
Karolinska Institutet